CCDC166
gene geneOn this page
Summary
CCDC166 (coiled-coil domain containing 166, HGNC:41910) is a protein-coding gene on chromosome 8q24.3, encoding Coiled-coil domain-containing protein 166 (P0CW27).
At a glance
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_001162914
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41910 |
| Approved symbol | CCDC166 |
| Name | coiled-coil domain containing 166 |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000255181 |
| Ensembl biotype | protein_coding |
| Entrez | 100130274 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000542437
RefSeq mRNA: 1 — MANE Select: NM_001162914
NM_001162914
CCDS: CCDS55280
Canonical transcript exons
ENST00000533508 — 0 exons
Expression profiles
Bgee: expression breadth broad, 13 present calls, max score 61.71.
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 61.71 | gold quality |
| right testis | UBERON:0004534 | 61.27 | gold quality |
| testis | UBERON:0000473 | 60.11 | gold quality |
| prefrontal cortex | UBERON:0000451 | 40.31 | silver quality |
| ganglionic eminence | UBERON:0004023 | 39.53 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 39.38 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 38.11 | gold quality |
| frontal cortex | UBERON:0001870 | 37.43 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 36.86 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| granulocyte | CL:0000094 | 36.25 | gold quality |
| primary visual cortex | UBERON:0002436 | 36.23 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| cerebral cortex | UBERON:0000956 | 35.10 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 34.80 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| tonsil | UBERON:0002372 | 31.38 | gold quality |
| skin of abdomen | UBERON:0001416 | 31.28 | silver quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 30.60 | gold quality |
| spleen | UBERON:0002106 | 30.18 | gold quality |
| lymph node | UBERON:0000029 | 30.07 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| urinary bladder | UBERON:0001255 | 29.43 | gold quality |
| skin of leg | UBERON:0001511 | 29.37 | gold quality |
| right uterine tube | UBERON:0001302 | 29.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| rattus_norvegicus | Ccdc166 | ENSRNOG00000047521 |
Paralogs (1): BBOF1 (ENSG00000119636)
Protein
Protein identifiers
Coiled-coil domain-containing protein 166 — P0CW27 (reviewed: P0CW27)
All UniProt accessions (1): P0CW27
RefSeq proteins (1): NP_001156386* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032777 | DUF4515 | Domain |
Pfam: PF14988
UniProt features (9 total): compositionally biased region 4, region of interest 2, coiled-coil region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CW27-F1 | 73.10 | 0.49 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, chr8q24, GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP, GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
206 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC166 | CRACDL | Q6NV74 | 507 |
| CCDC166 | ABTB3 | A6QL63 | 447 |
| CCDC166 | MEIG1 | Q5JSS6 | 447 |
| CCDC166 | FOXI2 | Q6ZQN5 | 415 |
| CCDC166 | ZNF704 | Q6ZNC4 | 410 |
| CCDC166 | IRF2BP1 | Q8IU81 | 399 |
| CCDC166 | NOM1 | Q5C9Z4 | 398 |
| CCDC166 | PCDHGB7 | Q9Y5F8 | 397 |
| CCDC166 | NUPR2 | A6NF83 | 397 |
| CCDC166 | SLC35F1 | Q5T1Q4 | 392 |
| CCDC166 | EPS8L1 | Q8TE68 | 378 |
| CCDC166 | ECHDC2 | Q86YB7 | 376 |
| CCDC166 | MICU3 | Q86XE3 | 374 |
| CCDC166 | SLC2A7 | Q6PXP3 | 370 |
| CCDC166 | UNC80 | Q8N2C7 | 370 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ITM2B | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A1A5D9, A1L3T7, A4FV37, A6NC98, A6NJZ7, A6NNM3, O15049, P0C7N4, P0CW27, P58660, Q0P5D1, Q1HGE8, Q2NL23, Q3LUD3, Q3UPH7, Q494R4, Q4QRL3, Q5JYT7, Q5ND29, Q5XIS1, Q64697, Q6QZQ4, Q6UXH0, Q6ZS72, Q7Z6P3, Q8BLS7, Q8C2K5, Q8C7U1, Q8CB62, Q8CB87, Q8CHW5, Q8N137, Q8R1L8, Q8TE77, Q8TER5, Q91VJ2, Q969G5, Q96EN9, Q96FF7, Q96LX7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
223 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:143707660:A:AC | donor_gain | 1.0000 |
| 8:143707661:C:CC | donor_gain | 1.0000 |
| 8:143707661:CTGG:C | donor_gain | 0.9900 |
| 8:143707570:C:CA | acceptor_loss | 0.9600 |
| 8:143707571:T:A | acceptor_loss | 0.9600 |
| 8:143707570:C:CC | acceptor_gain | 0.9200 |
| 8:143707572:G:C | acceptor_loss | 0.8600 |
| 8:143707876:G:C | donor_gain | 0.8500 |
| 8:143707872:CGTAG:C | donor_gain | 0.8300 |
| 8:143707567:CAC:C | acceptor_gain | 0.8200 |
| 8:143707568:AC:A | acceptor_gain | 0.8000 |
| 8:143707569:CC:C | acceptor_gain | 0.8000 |
| 8:143707565:AGCAC:A | acceptor_gain | 0.7700 |
| 8:143707661:CTG:C | donor_gain | 0.7200 |
| 8:143707692:G:A | donor_gain | 0.7200 |
| 8:143707566:GCAC:G | acceptor_gain | 0.7000 |
| 8:143707567:CACC:C | acceptor_gain | 0.7000 |
| 8:143707570:C:A | acceptor_gain | 0.7000 |
| 8:143707574:G:T | acceptor_gain | 0.6900 |
| 8:143707566:GCACC:G | acceptor_gain | 0.6800 |
| 8:143707718:T:TA | donor_gain | 0.6700 |
| 8:143707588:CAGCT:C | acceptor_loss | 0.6600 |
| 8:143707568:ACCTG:A | acceptor_gain | 0.6500 |
| 8:143707569:CCTGC:C | acceptor_gain | 0.6500 |
| 8:143707639:ACC:A | donor_gain | 0.6500 |
| 8:143707640:CCC:C | donor_gain | 0.6500 |
| 8:143707682:TCTTG:T | donor_gain | 0.6500 |
| 8:143707683:CTTGC:C | donor_gain | 0.6500 |
| 8:143707684:TTG:T | donor_gain | 0.6500 |
| 8:143707685:TGC:T | donor_gain | 0.6500 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1001540393 (8:143708054 G>A,C,T), RS1001874220 (8:143706515 C>T), RS1002540127 (8:143709168 C>A,T), RS1003158765 (8:143708875 C>A), RS1005566324 (8:143706851 G>A,C), RS1006078009 (8:143707456 G>A), RS1006578805 (8:143708463 C>G), RS1006629254 (8:143708635 C>G), RS1008919780 (8:143709508 A>C,T), RS1008968678 (8:143709776 A>G), RS1009800984 (8:143706581 T>C,G), RS10100154 (8:143708956 A>G,T), RS1010265492 (8:143706765 G>A,T), RS1010850286 (8:143708345 C>T), RS1011214877 (8:143708101 G>C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Endosulfan | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.